BNP PARIBAS FINANCIAL MARKETS - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESW and the CUSIP is 81362J118. A total of 8 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2019$79,880,000
-10.5%
446,2560.0%0.00%
Q3 2019$89,251,000
-13.0%
446,2560.0%0.00%
Q2 2019$102,639,000
+21.1%
446,2560.0%0.00%
Q1 2019$84,789,000
-24.0%
446,2560.0%0.00%
Q4 2018$111,564,000
-62.5%
446,2560.0%0.00%
Q3 2018$297,876,000
-1.8%
446,2560.0%0.00%
-100.0%
Q2 2018$303,454,000
-16.0%
446,2560.0%0.00%0.0%
Q1 2018$361,467,000
-3.6%
446,2560.0%0.00%0.0%
Q4 2017$374,855,000446,2560.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Anson Funds Management LP 1,337,580$2,568,0001.91%
Glassman Wealth Services 19,954$17,0000.01%
Psagot Value Holdings Ltd. 38,653$32,0000.00%
BNP PARIBAS FINANCIAL MARKETS 446,256$361,467,0000.00%
MORGAN STANLEY 443$00.00%
Financial Architects, Inc 1,406$1,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 394,717$339,0000.00%
UBS Group AG 6,047$5,0000.00%
IFP Advisors, Inc 692$1,0000.00%
NOMURA HOLDINGS INC 62,701$48,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders